Skip to main content

Articles

Page 130 of 163

  1. Patterns of decreasing malaria transmission intensity make presumptive treatment of malaria an unjustifiable approach in many African settings. The controlled use of anti-malarials after laboratory confirmed d...

    Authors: Guido JH Bastiaens, Erik Schaftenaar, Arnold Ndaro, Monique Keuter, Teun Bousema and Seif A Shekalaghe
    Citation: Malaria Journal 2011 10:76
  2. Sulphadoxine-pyrimethamine (SP) and chloroquine (CQ) have been used in treatment of falciparum and vivax malaria in Nepal. Recently, resistance to both drugs have necessitated a change towards artemisinin comb...

    Authors: Samir Ranjitkar, Mette L Schousboe, Thomas Thyge Thomsen, Madhav Adhikari, Christian MO Kapel, Ib C Bygbjerg and Michael Alifrangis
    Citation: Malaria Journal 2011 10:75
  3. Malaria pigment (haemozoin, Hz) has been the focus of diverse research efforts. However, identification of Hz-containing leukocytes or parasitized erythrocytes is usually based on microscopy, with inherent lim...

    Authors: Rosangela Frita, Maria Rebelo, Ana Pamplona, Ana M Vigario, Maria M Mota, Martin P Grobusch and Thomas Hänscheid
    Citation: Malaria Journal 2011 10:74
  4. After a national voucher scheme in 2004 provided pregnant women and infants with highly subsidized insecticide-treated nets (ITNs), use among children under five years (U5s) in mainland Tanzania increased from...

    Authors: Kimberly Bonner, Alex Mwita, Peter D McElroy, Susan Omari, Ally Mzava, Christian Lengeler, Naomi Kaspar, Rose Nathan, Joyce Ngegba, Romanus Mtung'e and Nick Brown
    Citation: Malaria Journal 2011 10:73
  5. It is generally agreed that in high transmission areas, pregnant women have acquired a partial immunity to malaria and when infected they present few or no symptoms. However, longitudinal cohort studies invest...

    Authors: Bich-Tram Huynh, Nadine Fievet, Gildas Gbaguidi, Sophie Borgella, Blaise Guézo Mévo, Achille Massougbodji, Philippe Deloron and Michel Cot
    Citation: Malaria Journal 2011 10:72
  6. The Plasmodium Cysteine Repeat Modular Proteins (PCRMP) are a family of four conserved proteins of malaria parasites, that contain a number of motifs implicated in host-parasite interactions. Analysis of mutants ...

    Authors: Bruno Douradinha, Kevin D Augustijn, Sally G Moore, Jai Ramesar, Maria M Mota, Andrew P Waters, Chris J Janse and Joanne Thompson
    Citation: Malaria Journal 2011 10:71
  7. Cerebral malaria (CM) is a major cause of malaria mortality. Sequestration of infected red blood cells and leukocytes in brain vessels coupled with the production of pro-inflammatory factors contribute to CM. ...

    Authors: Bismark Y Sarfo, Nana O Wilson, Vincent C Bond and Jonathan K Stiles
    Citation: Malaria Journal 2011 10:69
  8. The number of Anopheles arabiensis (Diptera: Culicidae) and Anopheles pharoensis caught by human and cattle baits was investigated experimentally in the Arba Minch district of southern Ethiopia to determine if at...

    Authors: Iňaki Tirados, Gabriella Gibson, Stephen Young and Stephen J Torr
    Citation: Malaria Journal 2011 10:68
  9. Presumptive treatment of malaria is common practice in malaria endemic resource-limited settings. With the changing epidemiology of malaria and the introduction of artemisinin-based combination therapy (ACT), ...

    Authors: Damalie Nakanjako, Agnes N Kiragga, Barbara Castelnuovo, Daniel J Kyabayinze and Moses R Kamya
    Citation: Malaria Journal 2011 10:66
  10. Despite years of effort, a licensed malaria vaccine is not yet available. One of the obstacles facing the development of a malaria vaccine is the extensive heterogeneity of many of the current malaria vaccine ...

    Authors: Keith Limbach, Joao Aguiar, Kalpana Gowda, Noelle Patterson, Esteban Abot, Martha Sedegah, John Sacci and Thomas Richie
    Citation: Malaria Journal 2011 10:65
  11. Home-management of malaria (HMM) strategy improves early access of anti-malarial medicines to high-risk groups in remote areas of sub-Saharan Africa. However, limited data are available on the effectiveness of...

    Authors: Billy E Ngasala, Maja Malmberg, Anja M Carlsson, Pedro E Ferreira, Max G Petzold, Daniel Blessborn, Yngve Bergqvist, José P Gil, Zul Premji and Andreas Mårtensson
    Citation: Malaria Journal 2011 10:64
  12. Previous investigations indicate that methotrexate, an old anticancer drug, could be used at low doses to treat malaria. A phase I evaluation was conducted to assess the safety and pharmacokinetic profile of t...

    Authors: Roma Chilengi, Rashid Juma, Ahmed M Abdallah, Mahfudh Bashraheil, Hudson Lodenyo, Priscilla Nyakundi, Evelyn Anabwani, Amina Salim, Gabriel Mwambingu, Ednah Wenwa, Julie Jemutai, Chemtai Kipkeu, George O Oyoo, Simon N Muchohi, Gilbert Kokwaro, Tim Niehues…
    Citation: Malaria Journal 2011 10:63
  13. In the first part of this study, an extensive literature survey led to the construction of a new version of the Liverpool Malaria Model (LMM). A new set of parameter settings was provided and a new development of...

    Authors: Volker Ermert, Andreas H Fink, Anne E Jones and Andrew P Morse
    Citation: Malaria Journal 2011 10:62
  14. Plant-based repellents have been used for generations in traditional practice as a personal protection measure against host-seeking mosquitoes. Knowledge on traditional repellent plants obtained through ethnob...

    Authors: Marta Ferreira Maia and Sarah J Moore
    Citation: Malaria Journal 2011 10(Suppl 1):S11

    This article is part of a Supplement: Volume 10 Supplement 1

  15. The clinical manifestations of cerebral malaria (CM) are well correlated with underlying major pathophysiological events occurring during an acute malaria infection, the most important of which, is the adheren...

    Authors: Patrice N Mimche, Donatella Taramelli and Livia Vivas
    Citation: Malaria Journal 2011 10(Suppl 1):S10

    This article is part of a Supplement: Volume 10 Supplement 1

  16. The outcomes from recent high profile deliberations concerning African health research and economic development all point towards the need for a mechanism to support health innovation on the continent. The mis...

    Authors: Ivan Addae-Mensah, Foluke Fakorede, Andreas Holtel and Solomon Nwaka
    Citation: Malaria Journal 2011 10(Suppl 1):S9

    This article is part of a Supplement: Volume 10 Supplement 1

  17. A “reverse pharmacology” approach to developing an anti-malarial phytomedicine was designed and implemented in Mali, resulting in a new standardized herbal anti-malarial after six years of research. The first ...

    Authors: Merlin L Willcox, Bertrand Graz, Jacques Falquet, Chiaka Diakite, Sergio Giani and Drissa Diallo
    Citation: Malaria Journal 2011 10(Suppl 1):S8

    This article is part of a Supplement: Volume 10 Supplement 1

  18. Over 1200 plant species are reported in ethnobotanical studies for the treatment of malaria and fevers, so it is important to prioritize plants for further development of anti-malarials.

    Authors: Merlin Willcox, Françoise Benoit-Vical, Dennis Fowler, Geneviève Bourdy, Gemma Burford, Sergio Giani, Rocky Graziose, Peter Houghton, Milijaona Randrianarivelojosia and Philippe Rasoanaivo
    Citation: Malaria Journal 2011 10(Suppl 1):S7

    This article is part of a Supplement: Volume 10 Supplement 1

  19. Recent studies on traditional medicine (TM) have begun to change perspectives on TM effects and its role in the health of various populations. The safety and effectiveness of some TMs have been studied, paving...

    Authors: Bertrand Graz, Andrew Y Kitua and Hamisi M Malebo
    Citation: Malaria Journal 2011 10(Suppl 1):S6

    This article is part of a Supplement: Volume 10 Supplement 1

  20. In the search for antimalarials from ethnobotanical origin, plant extracts are chemically fractionated and biological tests guide the isolation of pure active compounds. To establish the responsibility of isol...

    Authors: Eric Deharo and Hagai Ginsburg
    Citation: Malaria Journal 2011 10(Suppl 1):S5

    This article is part of a Supplement: Volume 10 Supplement 1

  21. In traditional medicine whole plants or mixtures of plants are used rather than isolated compounds. There is evidence that crude plant extracts often have greater in vitro or/and in vivo antiplasmodial activit...

    Authors: Philippe Rasoanaivo, Colin W Wright, Merlin L Willcox and Ben Gilbert
    Citation: Malaria Journal 2011 10(Suppl 1):S4

    This article is part of a Supplement: Volume 10 Supplement 1

  22. The discovery and development of new anti-malarials are at a crossroads. Fixed dose artemisinin combination therapy is now being used to treat a hundred million children each year, with a cost as low as 30 cen...

    Authors: Timothy NC Wells
    Citation: Malaria Journal 2011 10(Suppl 1):S3

    This article is part of a Supplement: Volume 10 Supplement 1

  23. Malaria continues to be an enormous global health challenge, with millions of new infections and deaths reported annually. This is partly due to the development of resistance by the malaria parasite to the maj...

    Authors: Eric Guantai and Kelly Chibale
    Citation: Malaria Journal 2011 10(Suppl 1):S2

    This article is part of a Supplement: Volume 10 Supplement 1

  24. Natural compounds, mostly from plants, have been the mainstay of traditional medicine for thousands of years. They have also been the source of lead compounds for modern medicine, but the extent of mining of n...

    Authors: Hagai Ginsburg and Eric Deharo
    Citation: Malaria Journal 2011 10(Suppl 1):S1

    This article is part of a Supplement: Volume 10 Supplement 1

  25. Rhoptries are specialized organelles from parasites belonging to the phylum Apicomplexa; they secrete their protein content during invasion of host target cells and are sorted into discrete subcompartments within...

    Authors: Gabriela Arévalo-Pinzón, Hernando Curtidor, Liliana C Patiño and Manuel A Patarroyo
    Citation: Malaria Journal 2011 10:60
  26. Knockdown resistance (kdr) in insects, resulting from mutation(s) in the voltage-gated sodium channel (vgsc) gene is one of the mechanisms of resistance against DDT and pyrethroid-group of insecticides. The most ...

    Authors: Om P Singh, Cherry L Dykes, Manila Lather, Om P Agrawal and Tridibes Adak
    Citation: Malaria Journal 2011 10:59
  27. In spite of enhanced control efforts, malaria remains a major public health problem causing close to a million deaths annually. With support from several donors, large amounts of artemisinin-based combination ...

    Authors: Andrea Kuemmerle, Alex NO Dodoo, Sten Olsson, Jan Van Erps, Christian Burri and Paul S Lalvani
    Citation: Malaria Journal 2011 10:57
  28. In sub-Saharan Africa, the distributions of malaria and HIV widely overlap. Among pregnant and non-pregnant adults, HIV affects susceptibility to malaria, its clinical course and impairs antibody responses to ...

    Authors: Daniel KM Muema, Francis M Ndungu, Samson M Kinyanjui and James A Berkley
    Citation: Malaria Journal 2011 10:55
  29. The development and spread of drug resistant Plasmodium falciparum strains is a major concern and novel anti-malarial drugs are, therefore, needed. Ferroquine is a ferrocenic derivative of chloroquine with proven...

    Authors: Ghyslain Mombo-Ngoma, Christian Supan, Matthias P Dal-Bianco, Michel A Missinou, Pierre-Blaise Matsiegui, Carmen L Ospina Salazar, Saadou Issifou, Daniel Ter-Minassian, Michael Ramharter, Maryvonne Kombila, Peter G Kremsner and Bertrand Lell
    Citation: Malaria Journal 2011 10:53
  30. The adhesion of Plasmodium falciparum parasitized red blood cell (PRBC) to human endothelial cells (EC) induces inflammatory processes, coagulation cascades, oxidative stress and apoptosis. These pathological pro...

    Authors: Zacharie Taoufiq, Paco Pino, Nadine N'dilimabaka, Issam Arrouss, Serge Assi, Florent Soubrier, Angelita Rebollo and Dominique Mazier
    Citation: Malaria Journal 2011 10:52
  31. Lumefantrine (benflumetol) is a fluorene derivative belonging to the aryl amino alcohol class of anti-malarial drugs and is commercially available in fixed combination products with β-artemether. Impurity char...

    Authors: Mathieu Verbeken, Sultan Suleman, Bram Baert, Elien Vangheluwe, Sylvia Van Dorpe, Christian Burvenich, Luc Duchateau, Frans H Jansen and Bart De Spiegeleer
    Citation: Malaria Journal 2011 10:51
  32. Malaria in Zambia remains a public health and developmental challenge, affecting mostly children under five and pregnant women. In 2002, the first-line treatment for uncomplicated malaria was changed to arteme...

    Authors: Michael Nambozi, Jean-Pierre Van Geertruyden, Sebastian Hachizovu, Mike Chaponda, Doreen Mukwamataba, Modest Mulenga, David Ubben and Umberto D'Alessandro
    Citation: Malaria Journal 2011 10:50
  33. In many malaria-endemic countries, increasing resistance may soon compromise the efficacy of sulphadoxine-pyrimethamine (SP) for intermittent preventative treatment (IPT) of malaria in pregnancy. Artemisinin-b...

    Authors: Marie A Onyamboko, Steven R Meshnick, Lawrence Fleckenstein, Matthew A Koch, Joseph Atibu, Victor Lokomba, Macaya Douoguih, Jennifer Hemingway-Foday, David Wesche, Robert W Ryder, Carl Bose, Linda L Wright, Antoinette K Tshefu and Edmund V Capparelli
    Citation: Malaria Journal 2011 10:49
  34. The accurate quantification of Plasmodium falciparum parasite numbers by PCR is an important tool for monitoring growth kinetics in subjects infected and subsequently treated with anti-malarial agents.

    Authors: Rebecca J Rockett, Sarah J Tozer, Chris Peatey, Seweryn Bialasiewicz, David M Whiley, Michael D Nissen, Katharine Trenholme, James S Mc Carthy and Theo P Sloots
    Citation: Malaria Journal 2011 10:48
  35. Nutritional iron deficiency may limit iron availability to the malaria parasite reducing infection risk, and/or impair host immunity thereby increasing this risk. In pregnant women, there is evidence of an adv...

    Authors: Edward L Senga, Gregory Harper, Gibby Koshy, Peter N Kazembe and Bernard J Brabin
    Citation: Malaria Journal 2011 10:47
  36. In Zanzibar, the Ministry of Health and partners accelerated malaria control from September 2003 onwards. The impact of the scale-up of insecticide-treated nets (ITN), indoor-residual spraying (IRS) and artemi...

    Authors: Maru W Aregawi, Abdullah S Ali, Abdul-wahiyd Al-mafazy, Fabrizio Molteni, Samson Katikiti, Marian Warsame, Ritha JA Njau, Ryuichi Komatsu, Eline Korenromp, Mehran Hosseini, Daniel Low-Beer, Anders Bjorkman, Umberto D'Alessandro, Marc Coosemans and Mac Otten
    Citation: Malaria Journal 2011 10:46
  37. Prompt, quality assured laboratory diagnosis is key to effective malaria case management and control, especially since the introduction of the more expensive artemisinin combination therapy (ACT). The malaria ...

    Authors: Muhammad Amir Khan, John D Walley, Muhammad Arif Munir, Muhammad Aslam Khan, Nayyar Ghias Khokar, Zarfishan Tahir, Athar Nazir and Nazia Shams
    Citation: Malaria Journal 2011 10:45
  38. In Thailand, the proportion of Plasmodium vivax infection has become equal to Plasmodium falciparum. Reports of a trend of gradual decline of in vitro sensitivity of P. vivax to chloroquine in some areas of the c...

    Authors: Poonuch Muhamad, Ronnatrai Ruengweerayut, Wanna Chacharoenkul, Kanchana Rungsihirunrat and Kesara Na-Bangchang
    Citation: Malaria Journal 2011 10:44
  39. Plasmodium falciparum chloroquine resistance (CQR) transporter protein (PfCRT) is known to be the important key of CQR. Recent studies have definitively demonstrated a link between mutations in the gene pfcrt and...

    Authors: Wanna Chaijaroenkul, Stephen A Ward, Mathirut Mungthin, David Johnson, Andrew Owen, Patrick G Bray and Kesara Na-Bangchang
    Citation: Malaria Journal 2011 10:42
  40. Intermittent preventive treatment of malaria in infants (IPTi) consists of the administration of a treatment dose of sulphadoxine-pyrimethamine (SP) at the time of routine vaccinations. The use of routine Heal...

    Authors: Barbara A Willey, Joanna RM Armstrong Schellenberg, Werner Maokola, Kizito Shirima, Mwajuma Chemba, Hassan Mshinda, Pedro Alonso, Marcel Tanner and David Schellenberg
    Citation: Malaria Journal 2011 10:41
  41. Antibodies to key Plasmodium falciparum surface antigens have been shown to be important effectors that mediate clinical immunity to malaria. The cross-strain fraction of anti-malarial antibodies may however be r...

    Authors: Kwadwo A Kusi, Bart W Faber, Marjolein van der Eijk, Alan W Thomas, Clemens HM Kocken and Edmond J Remarque
    Citation: Malaria Journal 2011 10:40
  42. The present study assessed malaria RDT kits for adequate and correct packaging, design and labelling of boxes and components. Information inserts were studied for readability and accuracy of information.

    Authors: Philippe Gillet, Jessica Maltha, Veerle Hermans, Raffaella Ravinetto, Cathrien Bruggeman and Jan Jacobs
    Citation: Malaria Journal 2011 10:39
  43. Quinine is still recommended as an effective therapy for severe cases of Plasmodium falciparum malaria, but the parasite has developed resistance to the drug in some cases. Investigations into the genetic basis f...

    Authors: Sébastien Briolant, Stéphane Pelleau, Hervé Bogreau, Philippe Hovette, Agnès Zettor, Jacky Castello, Eric Baret, Rémy Amalvict, Christophe Rogier and Bruno Pradines
    Citation: Malaria Journal 2011 10:37

Annual Journal Metrics

  • 2022 Citation Impact
    3.0 - 2-year Impact Factor
    3.2 - 5-year Impact Factor
    1.148 - SNIP (Source Normalized Impact per Paper)
    1.237 - SJR (SCImago Journal Rank)

    2023 Speed
    7 days submission to first editorial decision for all manuscripts (Median)
    131 days submission to accept (Median)

    2023 Usage 
    4,093,320 downloads
    5,053 Altmetric mentions